Table 1.
Demographic, clinical, and neuropathologic characteristics for NCI, MCI, and AD subjects
| Variables | NCI (n = 10) | MCI (n = 10) | AD (n = 10) |
|---|---|---|---|
| Age, yrs | 88.8 ± 4.8 (81.9 – 96.6) | 89.8 ± 3.7 (84.3 – 96.4) | 88.5 ± 3.0 (83.6 – 92.0) |
| % Males | 40 | 40 | 40 |
| Global cognitive functioning score | 0.26 ([−0.15] – [1.12]) | −0.21 ([−0.54] – [0.26]) | −1.31 ([−3.03] – [−1.08]) |
| MMSE score | 28.8 ± 1.1 (27 – 30) | 26.1 ± 2.2 (23 – 29) | 16.9 ± 2.3 (13 – 20) |
| NFT counts | 3.50 ± 2.68 (0.57 – 8.03) | 3.81 ± 2.53 (0.80 – 7.18) | 8.14 ± 5.87 (2.13 – 17.55) |
Summary statistics for age, MMSE scores, and NFT counts are shown as mean ± SD (top line) and range (bottom line), while global cognitive functioning scores are shown as median (top line) and range (bottom line). (NCI No cognitive impairment, MCI Mild cognitive impairment, AD Alzheimer’s disease, MMSE Mini Mental State Examination, NFT Neurofibrillary tangles)